UARK 2013-13, Total Therapy 4B - Formerly 2008-01 - A Phase III Trial for Low Risk Myeloma

Clinical trial NCT00734877 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT00734877
Sponsor: University of Arkansas
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2008-07-01
Primary completion: 2027-09-01
Enrollment: 382

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.